• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在药学干预与咨询过程中发现的药物相关问题:重症监护病房药学服务模式的实施

Drug-Related Problems Identified During Pharmacy Intervention and Consultation: Implementation of an Intensive Care Unit Pharmaceutical Care Model.

作者信息

Li Xiao-Xiao, Zheng Si-Qian, Gu Jia-Hui, Huang Tao, Liu Fang, Ge Qing-Gang, Liu Bin, Li Chao, Yi Min, Qin You-Fa, Zhao Rong-Sheng, Shi Lu-Wen

机构信息

Department of Pharmacy, Peking University Third Hospital, Beijing, China.

Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.

出版信息

Front Pharmacol. 2020 Sep 11;11:571906. doi: 10.3389/fphar.2020.571906. eCollection 2020.

DOI:10.3389/fphar.2020.571906
PMID:33013415
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7516263/
Abstract

AIM

To identify common drug-related problems (DRPs) during pharmacy intervention and consultation in an intensive care unit (ICU); to explore the gap between physicians and pharmacists on their understanding of each other's capabilities and needs.

METHOD

We conducted a single-center prospective study in the ICU of a tertiary academic hospital for 21 months. A pharmaceutical care (PC) model was implemented by a pharmacy team, and data were collected during pharmacy intervention and consultation. Data analysis was performed on identified DRPs, causes and their relationships. DRPs' frequency during intervention and consultation was compared. Problem-level descriptive analysis and network analysis were conducted using R 3.6.3.

RESULT

Implementation of PC model greatly improved the efficacy of pharmacists in both interventions proposed to solve DRPs (from 13.6 to 20.1 cases per month) and number of patients being closely monitored (from 7.7 to 16.9 per month). Pharmacists identified 427 DRPs during pharmacy intervention with primarily adverse drug events (ADEs, 34.7%) and effect of treatment not optimal (25.5%), and 245 DRPs during consultation (mainly ADEs, 58.4%). About three-fifths DRPs were caused by antibiotics. Comparing DRPs identified during pharmacy intervention and consultation, physicians consulted pharmacists more on questions related to medication safety, while pharmacists also paid attention to treatment effectiveness, which was consulted less commonly.

CONCLUSION

Implementation of PC model is beneficial in guiding pharmacy practice and improving efficacy especially under limited human resources. Physicians and pharmacists shall continue ensuring drug safety and be familiar with the scope of PC and clinical need for a better cooperation.

摘要

目的

识别重症监护病房(ICU)药学干预与咨询过程中常见的药物相关问题(DRP);探讨医生和药师在相互了解对方能力和需求方面的差距。

方法

在一家三级学术医院的ICU进行了一项为期21个月的单中心前瞻性研究。一个药学团队实施了药学服务(PC)模式,并在药学干预和咨询期间收集数据。对识别出的DRP、原因及其关系进行数据分析。比较干预和咨询期间DRP的发生频率。使用R 3.6.3进行问题层面的描述性分析和网络分析。

结果

PC模式的实施大大提高了药师在提出解决DRP的干预措施方面的效率(从每月13.6例增加到20.1例)以及密切监测的患者数量(从每月7.7例增加到16.9例)。药师在药学干预期间识别出427个DRP,主要是药物不良事件(ADE,34.7%)和治疗效果不佳(25.5%),在咨询期间识别出245个DRP(主要是ADE,58.4%)。约五分之三的DRP由抗生素引起。比较药学干预和咨询期间识别出的DRP,医生就药物安全相关问题向药师咨询更多,而药师也关注治疗效果,而这方面的咨询较少见。

结论

PC模式的实施有利于指导药学实践并提高效率,尤其是在人力资源有限的情况下。医生和药师应继续确保用药安全,并熟悉PC的范围和临床需求,以实现更好的合作。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dd4/7516263/0810912a5d86/fphar-11-571906-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dd4/7516263/6b7a8aa00af6/fphar-11-571906-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dd4/7516263/ed5d447f81ee/fphar-11-571906-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dd4/7516263/0810912a5d86/fphar-11-571906-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dd4/7516263/6b7a8aa00af6/fphar-11-571906-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dd4/7516263/ed5d447f81ee/fphar-11-571906-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dd4/7516263/0810912a5d86/fphar-11-571906-g003.jpg

相似文献

1
Drug-Related Problems Identified During Pharmacy Intervention and Consultation: Implementation of an Intensive Care Unit Pharmaceutical Care Model.在药学干预与咨询过程中发现的药物相关问题:重症监护病房药学服务模式的实施
Front Pharmacol. 2020 Sep 11;11:571906. doi: 10.3389/fphar.2020.571906. eCollection 2020.
2
Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital.土耳其一所大学附属医院临床药师对 ICU 患者药物相关问题的评估。
BMC Health Serv Res. 2022 Jan 15;22(1):79. doi: 10.1186/s12913-022-07494-5.
3
Characteristic of drug-related problems and pharmacists' interventions in a stroke unit in Thailand.药物相关问题的特征及药师在泰国卒中单元的干预措施。
Int J Clin Pharm. 2019 Aug;41(4):880-887. doi: 10.1007/s11096-019-00832-4. Epub 2019 May 3.
4
Drug-related problems identified by clinical pharmacists in nephrology department of a tertiary hospital in China-a single center study.中国一家三级医院肾病科临床药师发现的药物相关问题-一项单中心研究。
Ann Palliat Med. 2021 Aug;10(8):8701-8708. doi: 10.21037/apm-21-817.
5
Medication safety in a German telemedicine centre: Implementation of a telepharmaceutical expert consultation in addition to existing tele-intensive care unit services.德国远程医疗中心的药物安全:在现有远程重症监护服务的基础上,增设远程药学专家咨询。
J Telemed Telecare. 2020 Jan-Feb;26(1-2):105-112. doi: 10.1177/1357633X18799796. Epub 2018 Sep 25.
6
Identification and solution of drug-related problems in the neurology unit of a tertiary hospital in China.中国一家三甲医院神经内科的药物相关问题的识别与解决。
BMC Pharmacol Toxicol. 2021 Oct 26;22(1):65. doi: 10.1186/s40360-021-00530-w.
7
Evaluation of pharmacists' interventions on drug-related problems and drug costs in patients with cancer pain.评估药师干预癌症疼痛患者药物相关问题和药物费用的效果。
Int J Clin Pharm. 2021 Oct;43(5):1274-1282. doi: 10.1007/s11096-021-01247-w. Epub 2021 Feb 24.
8
Pharmaceutical care research and education project: pharmacists' interventions.药学服务研究与教育项目:药剂师的干预措施
J Am Pharm Assoc (Wash). 2001 May-Jun;41(3):401-10. doi: 10.1016/s1086-5802(16)31254-2.
9
Practical evaluation of the drug-related problem management process in Swiss community pharmacies.瑞士社区药房药物相关问题管理流程的实践评估
Pharm World Sci. 2008 Dec;30(6):777-86. doi: 10.1007/s11096-008-9217-4. Epub 2008 Apr 6.
10
Evaluation of Drug-Related Problems of Intensive Care Unit Patients by Clinical Pharmacists: A Retrospective Study.临床药师对重症监护病房患者药物相关问题的评估:一项回顾性研究。
Turk J Pharm Sci. 2024 Sep 2;21(4):274-283. doi: 10.4274/tjps.galenos.2023.44459.

引用本文的文献

1
The impact of pharmacist-led education and prospective audit and feedback on antibiotic dose optimization within medical intensive care units in Thailand: a retrospective study.药剂师主导的教育以及前瞻性审核与反馈对泰国医疗重症监护病房抗生素剂量优化的影响:一项回顾性研究。
J Pharm Policy Pract. 2025 Feb 28;18(1):2467456. doi: 10.1080/20523211.2025.2467456. eCollection 2025.
2
Impact of pharmacist-led interventions in identifying and resolving drug related problems and potentially inappropriate prescriptions among rural patients: A pilot study.药剂师主导的干预措施对识别和解决农村患者药物相关问题及潜在不适当处方的影响:一项试点研究。
Explor Res Clin Soc Pharm. 2024 Oct 24;16:100536. doi: 10.1016/j.rcsop.2024.100536. eCollection 2024 Dec.
3

本文引用的文献

1
The impact of physicians' knowledge on outpatient antibiotic use: Evidence from China's county hospitals.医生知识对门诊抗生素使用的影响:来自中国县级医院的证据。
Medicine (Baltimore). 2020 Jan;99(3):e18852. doi: 10.1097/MD.0000000000018852.
2
Evaluation of drug-related problems and subsequent clinical pharmacists' interventions at a Swiss university hospital.评估药物相关问题及随后临床药师在瑞士大学附属医院的干预措施。
J Clin Pharm Ther. 2019 Dec;44(6):924-931. doi: 10.1111/jcpt.13017. Epub 2019 Aug 13.
3
Impact of antimicrobial stewardship managed by clinical pharmacists on antibiotic use and drug resistance in a Chinese hospital, 2010-2016: a retrospective observational study.
Clinical pharmacist interventions in nutrition-and drug-related problems in critically ill patients with renal dysfunction: a non-randomized controlled study.临床药师对肾功能不全重症患者营养与药物相关问题的干预:一项非随机对照研究
Front Med (Lausanne). 2024 Oct 25;11:1473719. doi: 10.3389/fmed.2024.1473719. eCollection 2024.
4
Transforming respiratory diseases management: a CMO-based hospital pharmaceutical care model.变革呼吸系统疾病管理:基于首席医疗官的医院药学服务模式
Front Pharmacol. 2024 Oct 23;15:1461473. doi: 10.3389/fphar.2024.1461473. eCollection 2024.
5
Drug Therapy Problems Identified by Clinical Pharmacists at a General Surgery Ward of an Academic Referral Hospital in Jordan.约旦一家学术转诊医院普通外科病房临床药师发现的药物治疗问题。
Ther Clin Risk Manag. 2024 Sep 11;20:619-631. doi: 10.2147/TCRM.S465128. eCollection 2024.
6
Clinical pharmacist interventions in an intensive care unit reduces ICU mortality at a tertiary hospital in Dubai, United Arab Emirates.在阿拉伯联合酋长国迪拜的一家三级医院,临床药师在重症监护病房的干预措施降低了重症监护病房的死亡率。
Explor Res Clin Soc Pharm. 2024 Mar 9;14:100431. doi: 10.1016/j.rcsop.2024.100431. eCollection 2024 Jun.
7
Drug-related problems identified by clinical pharmacists in an academic medical centre in Thailand.泰国一家学术医疗中心的临床药剂师发现的与药物相关的问题。
J Pharm Policy Pract. 2023 Dec 16;17(1):2288603. doi: 10.1080/20523211.2023.2288603. eCollection 2024.
8
Impact of Clinical Pharmacist-Led Interventions on Drug-Related Problems Among Pediatric Cardiology Patients: First Palestinian Experience.临床药师主导的干预措施对儿科心脏病患者药物相关问题的影响:巴勒斯坦的首次经验。
Integr Pharm Res Pract. 2022 Aug 26;11:127-137. doi: 10.2147/IPRP.S374256. eCollection 2022.
9
Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital.土耳其一所大学附属医院临床药师对 ICU 患者药物相关问题的评估。
BMC Health Serv Res. 2022 Jan 15;22(1):79. doi: 10.1186/s12913-022-07494-5.
10
Pharmacists' Interventions on Electronic Prescriptions from Various Specialty Wards in a Malaysian Public Hospital: A Cross-Sectional Study.马来西亚一家公立医院药剂师对各专科病房电子处方的干预:一项横断面研究。
Pharmacy (Basel). 2021 Oct 1;9(4):161. doi: 10.3390/pharmacy9040161.
临床药师管理的抗菌药物管理对中国医院抗生素使用和耐药性的影响:一项回顾性观察研究,2010-2016 年。
BMJ Open. 2019 Aug 2;9(8):e026072. doi: 10.1136/bmjopen-2018-026072.
4
ASHP national survey of pharmacy practice in hospital settings: Workforce-2018.ASHP 医院药学实践状况全国调查:2018 年 workforce 报告
Am J Health Syst Pharm. 2019 Jul 18;76(15):1127-1141. doi: 10.1093/ajhp/zxz102.
5
Nutrition support for critically ill patients in China: role of the pharmacist.中国重症患者的营养支持:药剂师的作用
Asia Pac J Clin Nutr. 2019;28(2):246-251. doi: 10.6133/apjcn.201906_28(2).0006.
6
Effects of implementing a clinical pharmacist service in a mixed Norwegian ICU.在挪威一家混合型重症监护病房实施临床药师服务的效果
Eur J Hosp Pharm. 2016 Jul;23(4):197-202. doi: 10.1136/ejhpharm-2015-000751. Epub 2015 Nov 23.
7
Impact on Patient Outcomes of Pharmacist Participation in Multidisciplinary Critical Care Teams: A Systematic Review and Meta-Analysis.药师参与多学科危重病护理团队对患者结局的影响:系统评价和荟萃分析。
Crit Care Med. 2019 Sep;47(9):1243-1250. doi: 10.1097/CCM.0000000000003830.
8
Effect of physicians' knowledge on antibiotics rational use in China's county hospitals.医生知识对中国县级医院抗生素合理使用的影响。
Soc Sci Med. 2019 Mar;224:149-155. doi: 10.1016/j.socscimed.2019.01.049. Epub 2019 Jan 30.
9
Identify and categorize drug-related problems in hospitalized surgical patients in China.识别并分类中国住院手术患者中与药物相关的问题。
Int J Clin Pharm. 2019 Feb;41(1):13-17. doi: 10.1007/s11096-018-0777-7. Epub 2019 Jan 4.
10
Potential drug-related problems detected by routine pharmaceutical interventions: safety and economic contributions made by hospital pharmacists in Japan.通过常规药学干预发现的潜在药物相关问题:日本医院药师的安全与经济贡献
J Pharm Health Care Sci. 2018 Dec 13;4:33. doi: 10.1186/s40780-018-0125-z. eCollection 2018.